These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7651894)

  • 21. Characterization and photoaffinity labeling of a calcitonin gene-related peptide receptor solubilized from human cerebellum.
    Stangl D; Born W; Fischer JA
    Biochemistry; 1991 Sep; 30(35):8605-11. PubMed ID: 1653602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a calcitonin gene-related peptide receptor in a human neuroblastoma cell line (SK-N-MC) and a calcitonin receptor in a human breast carcinoma cell line (T47D).
    Muff R; Stangl D; Born W; Fischer JA
    Ann N Y Acad Sci; 1992 Jun; 657():106-16. PubMed ID: 1322087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
    Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
    Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesis.
    Drake WM; Ajayi A; Lowe SR; Mirtella A; Bartlett TJ; Clark AJ
    Endocrinology; 1999 Jan; 140(1):533-7. PubMed ID: 9886866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a putative calcitonin receptor in IMR 32 human neuroblastoma cells.
    Spampinato S; Falcucci B; Cacciaguerra S; Campana G; Murari G
    Neurosci Lett; 1999 Oct; 273(3):167-70. PubMed ID: 10515185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
    Rist B; Entzeroth M; Beck-Sickinger AG
    J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation and molecular identification of adrenomedullin binding sites in the rat spinal cord: a comparison with calcitonin gene-related peptide receptors.
    Owji AA; Gardiner JV; Upton PD; Mahmoodi M; Ghatei MA; Bloom SR; Smith DM
    J Neurochem; 1996 Nov; 67(5):2172-9. PubMed ID: 8863528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamine release mediates pressor effects of adrenomedullin-(15-22) in the rat.
    Champion HC; Fry RC; Murphy WA; Coy DH; Kadowitz PJ
    Hypertension; 1996 Dec; 28(6):1041-6. PubMed ID: 8952594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of receptors for calcitonin gene-related peptide and adrenomedullin on the guinea-pig vas deferens.
    Poyner DR; Taylor GM; Tomlinson AE; Richardson AG; Smith DM
    Br J Pharmacol; 1999 Mar; 126(5):1276-82. PubMed ID: 10205019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
    Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
    Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin-gene-related-peptide receptors, which mediate increased intracellular cAMP and inhibit mitogen-activated protein kinase activity.
    Coppock HA; Owji AA; Austin C; Upton PD; Jackson ML; Gardiner JV; Ghatei MA; Bloom SR; Smith DM
    Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):15-22. PubMed ID: 9931292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cys2,7EtalphaCGRP is a potent agonist for CGRP1 receptors in SK-N-MC cells.
    Nodin C; Vauquelin G; von Mentzer B
    Biochem Pharmacol; 2005 Apr; 69(8):1235-40. PubMed ID: 15794944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS.
    Schindler M; Doods HN
    Eur J Pharmacol; 2002 May; 442(3):187-93. PubMed ID: 12065071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
    Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
    Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines.
    Choksi T; Hay DL; Legon S; Poyner DR; Hagner S; Bloom SR; Smith DM
    Br J Pharmacol; 2002 Jul; 136(5):784-92. PubMed ID: 12086988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions.
    Muff R; Born W; Fischer JA
    Eur J Endocrinol; 1995 Jul; 133(1):17-20. PubMed ID: 7627335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proadrenomedullin NH(2)-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells.
    Moody TW; Coy D; Cuttitta F; Montuenga LM
    Peptides; 2000 Jan; 21(1):101-7. PubMed ID: 10704725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37).
    Chiba T; Yamaguchi A; Yamatani T; Nakamura A; Morishita T; Inui T; Fukase M; Noda T; Fujita T
    Am J Physiol; 1989 Feb; 256(2 Pt 1):E331-5. PubMed ID: 2537579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural determinants for binding to CGRP receptors expressed by human SK-N-MC and Col 29 cells: studies with chimeric and other peptides.
    Poyner DR; Soomets U; Howitt SG; Langel U
    Br J Pharmacol; 1998 Aug; 124(8):1659-66. PubMed ID: 9756381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat.
    Owji AA; Smith DM; Coppock HA; Morgan DG; Bhogal R; Ghatei MA; Bloom SR
    Endocrinology; 1995 May; 136(5):2127-34. PubMed ID: 7720662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.